# A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease

> **NCT02314689** · PHASE1 · COMPLETED · sponsor: **Suvankar Majumdar** · enrollment: 4 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Intravenous (IV) citrulline

## Key facts

- **NCT ID:** NCT02314689
- **Lead sponsor:** Suvankar Majumdar
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2019-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02314689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02314689, "A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02314689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*